Cutaneous Leishmaniasis: Clinical Trials

4 trials for Cutaneous Leishmaniasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Not yet recruiting 1
Phase 21Completed 1

Follow Cutaneous Leishmaniasis: new trials by email Literature Review of Cutaneous Leishmaniasis trials Research Report on Cutaneous Leishmaniasis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis
MILTEFOSINE gel - Cutaneous Leishmaniasis, Cutaneous Leishmaniasis, American
Phase 1Not yet recruitingUniversidad Industrial de Santander152026-01-012025-09-08
Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia
Topical Amphotericin B at 3% - Cutaneous Leishmaniasis
Phase 1 / Phase 2CompletedDrugs for Neglected Diseases802014-02-012016-07-26
Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite
Leish-111f + MPL-SE vaccine - Cutaneous Leishmaniasis
Phase 1CompletedAccess to Advanced Health Institute (AAHI)122005-08-012006-05-05
Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants
Combination of autoclaved leishmania antigen with recombinant human interleukin-12 (rhIL-12) and aluminum hydroxide gel as adjuvants - Cutaneous Leishmaniasis
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)501999-04-012008-03-04

Narrower conditions

Leishmaniasis, Cutaneous (4)  ·  Leishmaniasis (1)  ·  Leishmaniasis, Mucocutaneous (1)  ·  Parasitic Diseases (1)

Broader conditions

Euglenozoa Infections (4)  ·  Infections (4)  ·  Protozoan Infections (4)  ·  Skin Diseases (4)  ·  Skin Diseases, Infectious (4)  ·  Skin Diseases, Parasitic (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Vector Borne Diseases (4)  ·  Leishmaniasis (3)  ·  Parasitic Diseases (3)

Interventions

Interleukin-12 (1)  ·  miltefosine (1)

Sponsors

Access to Advanced Health Institute (AAHI) (1)  ·  Drugs for Neglected Diseases (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Universidad Industrial de Santander (1)

Countries

Colombia (3)  ·  United States (1)

Top investigators

Cristian Blanco, PhD (1)  ·  Ivan Dario Velez, Prof (1)

Results publications

PMID 11353640, PMID 30044792, PMID 30815688